Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,082 JPY | +0.74% | +1.31% | -15.47% |
2023 | KEIWA Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2021 | KEIWA Incorporated(TSE:4251) added to S&P Global BMI Index | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Its low valuation, with P/E ratio at 9.47 and 8.51 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.47% | 133M | - | ||
+5.42% | 103B | A- | ||
-1.80% | 65.6B | A- | ||
+39.52% | 39.06B | B | ||
+12.91% | 37.58B | B | ||
+7.41% | 33.26B | A- | ||
+6.85% | 19.22B | B- | ||
+12.86% | 16.83B | C+ | ||
+7.73% | 15.03B | B | ||
+16.93% | 14.96B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4251 Stock
- Ratings KEIWA Incorporated